Nash Marc 4

What Happened Marc Nash, EVP Operations, R&D & Service at Outset Medical (OM), sold 1,582 shares of company stock on 2026-05-15 at $3.70 per share, for proceeds of $5,853. The filing states this was a "sell to cover" transaction to satisfy tax withholding related to vested restricted stock units (RSUs) and is not a discretionary sale.

Key Details

• Transaction date and price: 2026-05-15, sale of 1,582 shares at $3.70 each (total $5,853).
• Purpose: Sell-to-cover to satisfy tax withholding on vesting of an aggregate 4,277 RSUs (granted 7/24/2023, 1/12/2024 and 6/10/2025). This indicates a tax-related disposition, not a routine investment decision.
• Correction noted: Footnote corrects a prior Form 4 (filed 2/19/2026) where an administrative error reported 1,817 shares instead of the correct 1,830 shares for a previous tax-withholding sale.
• Shares owned after transaction: Not disclosed in the provided excerpt.
• Filing timeliness: Transaction reported on Form 4 filed 2026-05-19 (transaction 2026-05-15), which is after the typical two-business-day reporting window — the filing appears late.

Context Sell-to-cover transactions are common when RSUs vest; they are executed to satisfy tax obligations and generally do not reflect an insider’s view on the company’s outlook. The filing includes an administrative correction to a prior reporting error; no discretionary trading pattern is indicated in this entry.